Hallucinations in patients with major depression
- 1 July 1985
- journal article
- research article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 9 (1) , 25-34
- https://doi.org/10.1016/0165-0327(85)90006-0
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Peptides in the cerebrospinal fluid of neuropsychiatric patients: An approach to central nervous system peptide functionLife Sciences, 1982
- Prolactin response to beta-endorphin in manLife Sciences, 1980
- Effects of enkephalin analogues on prolactin release in the ratLife Sciences, 1978
- PROLACTIN SECRETION, A MEASURABLE CENTRAL EFFECT OF OPIATE-RECEPTOR ANTAGONISTSThe Lancet, 1978
- Delusional Depressions: Natural History and Response to TreatmentThe British Journal of Psychiatry, 1977
- Enkephalin analogues and naloxone modulate the release of growth hormone and prolactin - evidence for regulation by an endogenous opioid peptide in brainLife Sciences, 1977
- Correlation of anxiety and related symptoms with cerebrospinal fluid 5-hydroxyindoleacetic acid in depressed womenJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1977
- Naloxone-induced reversal of schizophrenic hallucinationsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1977
- Morphine-like ligand for opiate receptors in human CSFLife Sciences, 1975
- Aggression in mice associated with changes in the monoamine-metabolism of the brainCellular and Molecular Life Sciences, 1969